2017
DOI: 10.1016/j.trsl.2016.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Cell therapy for the degenerating intervertebral disc

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
59
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 67 publications
(60 citation statements)
references
References 106 publications
1
59
0
Order By: Relevance
“…Traditional surgical treatments are able to alleviate pain symptoms in most instances but are not able to biologically restore normal disc functions. It is well established that biological therapies for disc degeneration are better able to restore normal disc function than previous traditional treatments [2]. Importantly, the normal biological function of NP cells (i.e., matrix biosynthesis) is important for the efficacy of the tissue-engineered NP tissue in regenerating disc degeneration [40].…”
Section: Discussionmentioning
confidence: 99%
“…Traditional surgical treatments are able to alleviate pain symptoms in most instances but are not able to biologically restore normal disc functions. It is well established that biological therapies for disc degeneration are better able to restore normal disc function than previous traditional treatments [2]. Importantly, the normal biological function of NP cells (i.e., matrix biosynthesis) is important for the efficacy of the tissue-engineered NP tissue in regenerating disc degeneration [40].…”
Section: Discussionmentioning
confidence: 99%
“…Disc degeneration largely contributes to low back and leg pain [29]. The chronic and progressive matrix degradation is the main pathological character during disc degeneration [30, 31].…”
Section: Discussionmentioning
confidence: 99%
“…There is therefore a tremendous unmet need for new treatment options for patients with disc degeneration and associated lower back pain. To address this need, there has been significant recent interest in developing injectable cell‐based therapies for the treatment of disc degeneration with the specific aim to stimulate tissue repair . Such therapies represent a potentially low risk and low cost long term solution for a very large patient population, making them attractive from both clinical and commercial standpoints.…”
Section: Introductionmentioning
confidence: 99%